Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era

Bibliographic Details
Main Authors: Coates, L, O’Dwyer, J, Meads, D, Emery, P, Conaghan, PG, Helliwell, P
Format: Journal article
Language:English
Published: Elsevier 2022
_version_ 1797107852437880832
author Coates, L
O’Dwyer, J
Meads, D
Emery, P
Conaghan, PG
Helliwell, P
author_facet Coates, L
O’Dwyer, J
Meads, D
Emery, P
Conaghan, PG
Helliwell, P
author_sort Coates, L
collection OXFORD
description
first_indexed 2024-03-07T07:19:58Z
format Journal article
id oxford-uuid:87d9aec0-122f-480e-8aaa-6bf5e60152c4
institution University of Oxford
language English
last_indexed 2024-03-07T07:19:58Z
publishDate 2022
publisher Elsevier
record_format dspace
spelling oxford-uuid:87d9aec0-122f-480e-8aaa-6bf5e60152c42022-10-04T12:19:42ZTreat-to-target in psoriatic arthritis—cost-effective in the biosimilar eraJournal articlehttp://purl.org/coar/resource_type/c_1843uuid:87d9aec0-122f-480e-8aaa-6bf5e60152c4EnglishSymplectic ElementsElsevier2022Coates, LO’Dwyer, JMeads, DEmery, PConaghan, PGHelliwell, P
spellingShingle Coates, L
O’Dwyer, J
Meads, D
Emery, P
Conaghan, PG
Helliwell, P
Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
title Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
title_full Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
title_fullStr Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
title_full_unstemmed Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
title_short Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
title_sort treat to target in psoriatic arthritis cost effective in the biosimilar era
work_keys_str_mv AT coatesl treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera
AT odwyerj treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera
AT meadsd treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera
AT emeryp treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera
AT conaghanpg treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera
AT helliwellp treattotargetinpsoriaticarthritiscosteffectiveinthebiosimilarera